Nisa Investment Advisors, LLC Kezar Life Sciences, Inc. Transaction History

Nisa Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 25, 2024	BUY	$0.72 - $1.15 $36 - $57	50 New	50 $0
Q2 2023 Aug 11, 2023	BUY	$2.31 - $3.06 $7,807 - $10,342	3,380 Added 926.03%	3,745 $9,000
Q1 2023 May 02, 2023	SELL	$3.13 - $7.31 $175 - $409	-56 Reduced 13.3%	365 $1,000
Q4 2022 Feb 02, 2023	BUY	$6.39 - $8.8 $357 - $492	56 Added 15.34%	421 $3,000
Q1 2022 Apr 29, 2022	SELL	$12.3 - $18.33 $14,391 - $21,446	-1,170 Reduced 76.22%	365 $6,000
Q4 2020 Jan 25, 2021	BUY	$4.77 - $6.58 $3,815 - $5,264	800 Added 108.84%	1,535 $8,000
Q2 2020 Jul 27, 2020	SELL	$3.6 - $7.75 $10,098 - $21,738	-2,805 Reduced 79.24%	735 $4,000
Q1 2020 Apr 17, 2020	BUY	$2.77 - $5.75 $9,805 - $20,355	3,540 New	3,540 $15,000

38.4M

13.8K

600

Ticker KZR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,369,504
Market Cap $430M
Description
Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...

Get notified when there are updates to the investment portfolio of Nisa Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Nisa Investment Advisors, LLC with notifications on news.